Published in J Pers Assess on July 01, 2008
Long-term recovery of normal sexual function in testicular cancer survivors. Asian J Androl (2015) 0.75
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst (2005) 4.48
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. J Natl Cancer Inst (2006) 2.91
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care (2003) 2.38
Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. Lancet Oncol (2007) 2.19
Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer. J Natl Cancer Inst (2008) 2.15
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Breast Cancer Res Treat (2008) 1.82
Switching benchmarks in cancer of unknown primary: from autopsy to microarray. Eur J Cancer (2007) 1.71
Cancer and pregnancy: poena magna, not anymore. Eur J Cancer (2005) 1.70
Trabectedin-related rhabdomyolysis: an uncommon but fatal toxicity. Tumori (2011) 1.56
Old habits die hard: chest radiography for screening purposes in primary care. Am J Manag Care (2006) 1.50
Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival. Breast Cancer Res Treat (2006) 1.43
Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. J Natl Cancer Inst (2006) 1.42
CENP-B specific anti-centromere autoantibodies heralding small-cell lung cancer. A case study and review of the literature. Lung Cancer (2007) 1.39
The role of catastrophizing in the prediction of postoperative pain. Pain Med (2009) 1.32
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes. BMC Cancer (2013) 1.32
Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis. Cancer Treat Rev (2009) 1.25
Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies. Cancer Treat Rev (2012) 1.24
Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part I: Solid tumors. Cancer Treat Rev (2009) 1.20
Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer (2010) 1.20
Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer. Clin Cancer Res (2009) 1.17
Management of leptomeningeal malignancy. Expert Opin Pharmacother (2005) 1.17
Unexplained fatigue syndromes in a multinational primary care sample: specificity of definition and prevalence and distinctiveness from depression and generalized anxiety. Am J Psychiatry (2003) 1.15
Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review. Crit Rev Oncol Hematol (2009) 1.13
Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors. Semin Oncol (2009) 1.09
Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review. Cancer Treat Rev (2008) 1.08
Temporal relations between unexplained fatigue and depression: longitudinal data from an international study in primary care. Psychosom Med (2004) 1.08
Cross-cultural differences in the epidemiology of unexplained fatigue syndromes in primary care. Br J Psychiatry (2003) 1.07
Psychiatric manifestations and personality traits associated with compliance with glaucoma treatment. J Psychosom Res (2006) 1.06
Neuroendocrine carcinoma of unknown primary: a systematic review of the literature and a comparative study with other neuroendocrine tumors. Cancer Treat Rev (2011) 1.05
Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence. Breast Cancer Res Treat (2010) 1.05
Presentation, management and outcome of 32 patients with pregnancy-associated breast cancer: a matched controlled study. Breast J (2009) 1.05
Cancer of unknown primary site: missing primary or missing biology? Oncologist (2007) 1.03
Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors. Cancer Treat Rev (2009) 1.03
Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1. BMC Cancer (2005) 1.02
Possible neuroleptic malignant syndrome during paliperidone administration: a case report. J Clin Psychopharmacol (2010) 1.02
Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol (2010) 1.00
The relationship between religious coping, psychological distress and quality of life in hemodialysis patients. J Psychosom Res (2012) 0.98
Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: accumulating evidence of efficacy, synergy and safety. Crit Rev Oncol Hematol (2007) 0.97
Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature. Cancer Treat Rev (2008) 0.96
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Breast Cancer Res Treat (2005) 0.95
Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study. Breast Cancer Res Treat (2011) 0.94
Prognostication in cancer of unknown primary (CUP): development of a prognostic algorithm in 311 cases and review of the literature. Cancer Treat Rev (2013) 0.93
Successful publishing: how to get your paper accepted. Surg Oncol (2008) 0.93
Personality variables are associated with colorectal cancer patients' quality of life independent of psychological distress and disease severity. Psychooncology (2010) 0.92
Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: an overview of survival data. Eur J Cancer (2006) 0.92
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression. Clin Breast Cancer (2012) 0.91
Does psychological distress vary between younger and older adults in health and disease? J Psychosom Res (2011) 0.91
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors. Crit Rev Oncol Hematol (2008) 0.90
Treatment of colorectal cancer in the elderly: a review of the literature. Cancer Treat Rev (2005) 0.90
Exploring the biology of cancer of unknown primary: breakthroughs and drawbacks. Eur J Clin Invest (2013) 0.90
Lung cancer in the pregnant woman: to treat or not to treat, that is the question. Lung Cancer (2009) 0.89
Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study. Clin Neuropharmacol (2010) 0.89
Psychological distress, somatization, and defense mechanisms associated with quality of life in inflammatory bowel disease patients. Dig Dis Sci (2009) 0.89
Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psychosom Res (2007) 0.89
Important drug safety information on the internet: assessing its accuracy and reliability. Drug Saf (2003) 0.88
Matrix metalloproteinases in carcinoma of unknown primary. Cancer (2005) 0.87
The integrative management of treatment-resistant depression: a comprehensive review and perspectives. Psychother Psychosom (2014) 0.87
An empirical investigation of the structure of anxiety and depressive symptoms in late adolescence: cross-sectional study using the Greek version of the revised Clinical Interview Schedule. Psychiatry Res (2010) 0.87
Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel. Cancer Chemother Pharmacol (2004) 0.87
Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Anticancer Res (2012) 0.87
Metastatic breast carcinoma confined to bone: portrait of a clinical entity. Cancer (2004) 0.86
The impact of psychological functioning upon systemic sclerosis patients' quality of life. Semin Arthritis Rheum (2007) 0.86
Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration. J Psychiatr Res (2013) 0.86
Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary site. Psychooncology (2013) 0.86
Anticonvulsant drugs for pediatric migraine prevention: an evidence-based review. Eur J Pain (2008) 0.85
Defensive coping and health-related quality of life in chronic kidney disease: a cross-sectional study. BMC Nephrol (2011) 0.85
Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunction. Anticancer Drugs (2006) 0.85
Effects of different chemotherapy regimens on survival for advanced cervical cancer: systematic review and meta-analysis. Cancer Treat Rev (2006) 0.85
Colorectal cancer screening awareness in European primary care. Cancer Detect Prev (2006) 0.85
Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target? Clin Exp Metastasis (2007) 0.84
Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study. Clin Lung Cancer (2010) 0.84
Prevalence and sociodemographic associations of common mental disorders in a nationally representative sample of the general population of Greece. BMC Psychiatry (2013) 0.84
Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive-compulsive disorder: a meta-analysis of the randomized controlled trials. Eur Neuropsychopharmacol (2006) 0.84
Socioeconomic inequalities in general and psychological health among adolescents: a cross-sectional study in senior high schools in Greece. Int J Equity Health (2010) 0.84
Somatization is associated with physical health-related quality of life independent of anxiety and depression in cancer, glaucoma and rheumatological disorders. Qual Life Res (2009) 0.84
Bullying behaviour in schools, socioeconomic position and psychiatric morbidity: a cross-sectional study in late adolescents in Greece. Child Adolesc Psychiatry Ment Health (2012) 0.84
Personality variables as predictors of early non-metastatic colorectal cancer patients' psychological distress and health-related quality of life: a one-year prospective study. J Psychosom Res (2010) 0.83
Cognitive dysfunction in depression - pathophysiology and novel targets. CNS Neurol Disord Drug Targets (2014) 0.83
The impact of the metabolic syndrome on health-related quality of life: a cross-sectional study in Greece. Eur J Cardiovasc Nurs (2012) 0.83
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study. Anticancer Res (2005) 0.83
Personality correlates of adherence to type 2 diabetes regimens. Int J Psychiatry Med (2005) 0.83
BDNF serum concentrations in first psychotic episode drug-naïve schizophrenic patients: associations with personality and BDNF Val66Met polymorphism. Life Sci (2013) 0.82
Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary. Clin Exp Metastasis (2012) 0.82
Lung cancer during pregnancy: an emerging issue. Lung Cancer (2007) 0.82
Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary. Mol Cancer (2013) 0.82
Is the personality characteristic "impulsive sensation seeking" correlated to differences in current smoking between ulcerative colitis and Crohn's disease patients? Gen Hosp Psychiatry (2009) 0.81
Screening for bipolar disorder in the primary care: a Brazilian survey. J Affect Disord (2012) 0.81
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphoma. Hematol J (2003) 0.81
Donor-derived breast cancer in a bone marrow transplantation recipient. Breast Cancer Res Treat (2008) 0.81
The association between Type D personality and the metabolic syndrome: a cross-sectional study in a University-based outpatient lipid clinic. BMC Res Notes (2011) 0.81
Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective? Acta Oncol (2005) 0.81
The relationship between affective temperaments, defensive styles and depressive symptoms in a large sample. J Affect Disord (2012) 0.80
Treatment engagement of psychotic patients with a mobile mental health unit in rural areas in Greece: a five-year study. Schizophr Res Treatment (2013) 0.80